Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge

We never sell data.

We never share data.

Data never leaves Sensyne's control.

We only use data for the purposes of medical research to improve patient outcomes and accelerate the development of new medicines.

Sensyne Health | The future of healthcare

Our mission

To improve health and create wealth for all through the ethical application of clinical artificial intelligence and the creation of a trusted data community between patients, clinicians, healthcare providers and life science companies that is transparent, fair and effective.

Sensyne Health is a clinical artificial intelligence company operating a unique business model. We are a for-profit plc making a positive social impact, sharing the financial returns we make with the health systems via equity and a share of revenues.

The company applies Clinical AI in two markets:

Our work

Sensight video

A real world patient data analytics platform for the life sciences and healthcare industries

SENSIGHT is the first data analytics platform to provide industrial scale access to anonymised and de-identified real world data insights globally across multiple therapy areas.

More about SENSIGHT

A unique approach

We have created a unique commercial approach to benefit patients, healthcare providers and the life science industry – a for-profit plc making a positive social impact. Providing both a financial return to health systems via equity and/or a share in revenues, and a patient outcome ‘return’ advancing care delivery and disease research and development.
Respiratory
Respiratory
Cardiovascular
Cardiovascular
Neurodegenerative
Neurodegenerative
Immunological
Immunological
Cancer
Cancer

Our Strategic Research Agreements (SRAs) with healthcare providers allow us access to globally unique, longitudinal de-identified and anonymised patient datasets.

Strategic Research Agreements

Our presence

Our product adoption and Strategic Research Agreement data footprint

GDm-Health

279,000

Population served

16,000

Patients monitored

SEND

925,000

Population served

363,540

Patients monitored

BPm-Health

33,310

Population served

166

Patients monitored

Strategic Research
Agreement

22,500,000

Patient records

Data Access
Agreement

1,100,000

Patient records

Areas we cover

Sensyne has access to anonymised and de-identified data insights on over 22.5m patients across the UK’s NHS Trusts and US health systems.  We also supply Clinical AI software for remote patient monitoring to >50% of NHS England Trusts.

Life sciences - we work with pharmaceutical companies to analyse real world data from electronic patient records to accelerate medical research.

Healthcare - we work with health systems to supply advanced software that enables better care of patients remotely.

Blogs

Latest news